Kathleen D. Scott insider trades: Dermata Therapeutics (DRMA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kathleen reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | DRMA | ↓ Sell | 11 | $1.19 | $13 | Direct | Jun 16, 2026 (0d) |
| Aug 21, 2025 | SPRY | ↓ Sell10b5-1 | 12,500 | $15.00 | $188K | Direct | Aug 22, 2025 (1d) |
| May 20, 2025 | SPRY | ↓ Sell | 50,000 | $14.10 | $705K | Direct | May 22, 2025 (2d) |
| Oct 16, 2024 | SPRY | ↓ Sell | 12,500 | $16.00 | $200K | Direct | Oct 17, 2024 (1d) |
| Aug 20, 2024 | SPRY | ↓ Sell | 12,500 | $16.00 | $200K | Direct | Aug 21, 2024 (1d) |
| Nov 29, 2022 | SPRY | ↑ Buy | 8,250 | $6.24 | $52K | Indirect | Dec 1, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DRMA insiders
Open-market trades in the last 12 months
About Kathleen D. Scott's insider trades
Kathleen D. Scott is a director at Dermata Therapeutics (DRMA). Since Nov 29, 2022, Kathleen has reported 1 open-market purchase worth $52K and 5 sales worth $1.3M on SEC Form 4. In the last 12 months: 1 sale ($13).
1 sale (15% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (16 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DRMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.